Nasal CDMO Strength Renaissance Lakewood is a specialized CDMO with over 20 years of experience in nasal spray development and aseptic fill-finish manufacturing, offering end-to-end support from development to commercial launch.

Expansion and Capacity Recent facility expansions and new packaging lines, plus a large 67,000 sq ft warehouse, indicate growing capacity to meet rising demand and accelerate time-to-market for nasal and sterile injectable products.

Strategic Partnerships Active collaborations and licensing activities with industry players such as ARS and St. Jude, plus a disclosed collaboration with Tiziana Life Sciences, suggest fertile opportunities for co-development and early-stage programs.

Compliance and Scope Capability to handle DEA Schedule I-V products and a broad suite of analytical, spray characterization, and formulation services positions Renaissance to support regulated, multi-dose nasal therapies and complex sterile products.

Financial and Market Position Estimated revenue in the mid-range hundred millions with a focused geographic footprint in the US; a mid-sized CDMO profile offers a strong partner for mid-market biotechs seeking agile, responsive manufacturing and development partners.